Chargement en cours...
Targeting β-amyloid pathology in Alzheimer’s disease with Aβ immunotherapy
More than 10 clinical trials of Aβ immunotherapy are currently underway in patients with Alzheimer’s disease (AD). The aim is to identify safe approaches for the efficacious antibody-mediated removal of brain β-amyloid or its neurotoxic oligomeric precursors consisting of aggregated amyloid β-peptid...
Enregistré dans:
| Publié dans: | Neurotherapeutics |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer-Verlag
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084243/ https://ncbi.nlm.nih.gov/pubmed/18625453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.05.013 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|